APA (7th ed.) Citation

He, S., Niu, G., Shang, J., Deng, Y., Wan, Z., Zhang, C., . . . Shen, H. (2025). Retraction Note: The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. Journal of experimental & clinical cancer research, 44(1), 71-1. https://doi.org/10.1186/s13046-025-03344-4

Chicago Style (17th ed.) Citation

He, Shanyang, Gang Niu, Jianhong Shang, Yalan Deng, Zhiyong Wan, Cai Zhang, Zeshan You, and Hongwei Shen. "Retraction Note: The Oncogenic Golgi Phosphoprotein 3 like Overexpression Is Associated with Cisplatin Resistance in Ovarian Carcinoma and Activating the NF-κB Signaling Pathway." Journal of Experimental & Clinical Cancer Research 44, no. 1 (2025): 71-1. https://doi.org/10.1186/s13046-025-03344-4.

MLA (9th ed.) Citation

He, Shanyang, et al. "Retraction Note: The Oncogenic Golgi Phosphoprotein 3 like Overexpression Is Associated with Cisplatin Resistance in Ovarian Carcinoma and Activating the NF-κB Signaling Pathway." Journal of Experimental & Clinical Cancer Research, vol. 44, no. 1, 2025, pp. 71-1, https://doi.org/10.1186/s13046-025-03344-4.